Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy

Crit Care Med. 1986 May;14(5):514-6. doi: 10.1097/00003246-198605000-00019.

Abstract

We treated two pediatric patients suffering respiratory failure associated with status asthmaticus. Neither patient responded to maximal bronchodilatory therapy and mechanical ventilation; however, continuous infusion of ketamine (1.0 to 2.5 mg/kg X h) immediately improved airway obstruction. Ketamine appears to increase catecholamine levels and directly relax bronchial smooth muscle. Except for increased secretions during the infusion, our patients showed no immediate or long-term sequelae from ketamine therapy. However, ketamine should only be used for asthmatics whose respiratory failure does not respond to conventional management and mechanical ventilation.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adolescent
  • Asthma / complications*
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Emergencies
  • Female
  • Humans
  • Infusions, Parenteral
  • Intubation, Intratracheal
  • Isoproterenol / administration & dosage
  • Ketamine / administration & dosage
  • Ketamine / therapeutic use*
  • Male
  • Respiratory Insufficiency / drug therapy*
  • Respiratory Insufficiency / etiology
  • Status Asthmaticus / complications*
  • Suction

Substances

  • Ketamine
  • Isoproterenol